| Dr Tyler James Willenbrink, MD | |
|
575 Coal Valley Rd Ste 360, Clairton, PA 15025-3739 | |
| (412) 466-9400 | |
| Not Available |
| Full Name | Dr Tyler James Willenbrink |
|---|---|
| Gender | Male |
| Speciality | Dermatology - Mohs-micrographic Surgery |
| Location | 575 Coal Valley Rd Ste 360, Clairton, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306367396 | NPI | - | NPPES |
| Entity Name | Zitelli & Brodland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184790099 PECOS PAC ID: 4284622978 Enrollment ID: O20040503000648 |
News Archive
Today the discoverer of Anti-Aging effects of fruit acids Patent # US5153230A has announced the introduction of a new rechargeable electronic skin care device MURSAL®RF which works on Radio Frequency.
Each year, the American Thyroid Association (ATA) recognizes the outstanding research contributions of one of its members to a greater understanding of thyroid physiology or the pathophysiology of thyroid disease, with its presentation of the John B. Stanbury Pathophysiology Medal at its Annual Meeting.
BeaconEquity.com announces an investment report featuring biotech company Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tyler James Willenbrink, MD 575 Coal Valley Rd Ste 360, Clairton, PA 15025-3739 Ph: () - | Dr Tyler James Willenbrink, MD 575 Coal Valley Rd Ste 360, Clairton, PA 15025-3739 Ph: (412) 466-9400 |
News Archive
Today the discoverer of Anti-Aging effects of fruit acids Patent # US5153230A has announced the introduction of a new rechargeable electronic skin care device MURSAL®RF which works on Radio Frequency.
Each year, the American Thyroid Association (ATA) recognizes the outstanding research contributions of one of its members to a greater understanding of thyroid physiology or the pathophysiology of thyroid disease, with its presentation of the John B. Stanbury Pathophysiology Medal at its Annual Meeting.
BeaconEquity.com announces an investment report featuring biotech company Spectrum Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Pharmaxis, Inc., a wholly owned subsidiary of Pharmaxis Ltd , an emerging respiratory specialty pharmaceutical company, announced today that it has filed a New Drug Application (NDA), electronically, with the U.S. Food and Drug Administration (FDA) for Aridol (mannitol bronchial challenge test).
› Verified 7 days ago